Revenue Increased 17% Quarter over QuarterOperating Loss Decreased 27% Management to Host Conference Call Today at 5:00 pm ETLITTLETON, Colo., ...
Vivos Therapeutics, Inc. ( NASDAQ: VVOS) Q3 2024 Earnings Conference Call November 14, 2024 5:00 PM ET Kirk Huntsman - Chariman & CEO Brad Amman - CFO Scott Henry - Alliance Global Partners Lucas Ward ...
The Vivos treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. Vivos ...
Our CARE oral medical devices are ... by more than 2,000 trained dentists. The Vivos Method includes treatment regimens that employ proprietary CARE appliance therapy and other modalities that ...
LITTLETON, Colo., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company ...
Our CARE oral medical devices are the only ... treatment options and help promote sales of its appliances. For more information, visit www.vivos.com. Cautionary Note Regarding Forward-Looking ...
Our CARE oral medical devices are the only ones cleared ... to offer patients OSA treatment options and help promote sales of its appliances. For more information, visit www.vivos.com. This press ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback